Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/19/23 16:49 | 9/15/23 | AMAM | Health | BioPrd | Biological Products, (No Diag | Cormorant Asset Management, LP | MA | T | P.m | 19,626 | 9.12 | 0 | 2,153 | 3 | 69,466 | I | |||||||||||||||
4/20/23 18:04 | 4/18/23 | AMAM | Health | BioPrd | Biological Products, (No Diag | Cormorant Asset Management, LP | MA | T | P.m | 58,951 | 11.30 | 0 | 5,215 | 8 | 67,313 | I | |||||||||||||||
4/17/23 17:46 | 4/13/23 | AMAM | Health | BioPrd | Biological Products, (No Diag | Cormorant Asset Management, LP | MA | T | P.m | 25,319 | 9.75 | 0 | 2,598 | 4 | 62,098 | I | |||||||||||||||
3/16/23 18:04 | 3/14/23 | AMAM | Health | BioPrd | Biological Products, (No Diag | Cormorant Asset Management, LP | MA | T | P.m | 10,211 | 10.21 | 0 | 1,000 | 2 | 53,500 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |